145 related articles for article (PubMed ID: 24817913)
1. A study of antibiogram of Salmonella enterica serovar Typhi isolates from Pondicherry, India.
Srirangaraj S; Kali A; Charles MV
Australas Med J; 2014; 7(4):185-90. PubMed ID: 24817913
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial susceptibility of Salmonella enterica serovars in a tertiary care hospital in southern India.
Choudhary A; Gopalakrishnan R; Nambi PS; Ramasubramanian V; Ghafur KA; Thirunarayan MA
Indian J Med Res; 2013 Apr; 137(4):800-2. PubMed ID: 23703350
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial Resistance in
Khadka S; Shrestha B; Pokhrel A; Khadka S; Joshi RD; Banjara MR
Microbiol Insights; 2021; 14():11786361211056350. PubMed ID: 34916803
[TBL] [Abstract][Full Text] [Related]
4. Predictive efficacy of nalidixic acid resistance as a marker of fluoroquinolone resistance in Salmonella enterica var Typhi.
Ray P; Sharma J; Marak RS; Garg RK
Indian J Med Res; 2006 Jul; 124(1):105-8. PubMed ID: 16926465
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial susceptibility to azithromycin among Salmonella enterica Typhi and Paratyphi A isolates from India.
Misra R; Prasad KN
J Med Microbiol; 2016 Dec; 65(12):1536-1539. PubMed ID: 27902389
[TBL] [Abstract][Full Text] [Related]
6. Reduced minimum inhibitory concentration of chloramphenicol for Salmonella enterica serovar typhi.
Mandal S; Mandal MD; Pal NK
Indian J Med Sci; 2004 Jan; 58(1):16-23. PubMed ID: 14960797
[TBL] [Abstract][Full Text] [Related]
7. Trends in antibiotic susceptibility of enteric fever isolates in East London.
Dave J; Sefton A; de Pinna E; Woodford N; Meade R; Jordan M; Grant K; Holliman R; Millar M
Travel Med Infect Dis; 2015; 13(3):230-4. PubMed ID: 25964222
[TBL] [Abstract][Full Text] [Related]
8. Renaissance of Conventional First-Line Antibiotics in
Khanal PR; Satyal D; Bhetwal A; Maharjan A; Shakya S; Tandukar S; Parajuli NP
Biomed Res Int; 2017; 2017():2868143. PubMed ID: 29018810
[TBL] [Abstract][Full Text] [Related]
9. Revisit of fluoroquinolone and azithromycin susceptibility breakpoints for Salmonella enterica serovar Typhi.
Das S; Ray U; Dutta S
J Med Microbiol; 2016 Jul; 65(7):632-640. PubMed ID: 27221661
[TBL] [Abstract][Full Text] [Related]
10. Multi-drug resistant Salmonella enterica serovar Typhi isolates with reduced susceptibility to ciprofloxacin in Kenya.
Mutai WC; Muigai AWT; Waiyaki P; Kariuki S
BMC Microbiol; 2018 Nov; 18(1):187. PubMed ID: 30428828
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibility profile, treatment outcome and serotype distribution of clinical isolates of
Harichandran D; Dinesh KR
Infect Drug Resist; 2017; 10():97-101. PubMed ID: 28352198
[TBL] [Abstract][Full Text] [Related]
12. Novel restriction enzyme SSiI for the detection of mutation in GyrA gene of Salmonella enterica serovar Typhi.
Agrawal P; Kapila K; Kumar S; Ghosh AN; Maurya AK
Indian J Pathol Microbiol; 2010; 53(3):509-12. PubMed ID: 20699513
[TBL] [Abstract][Full Text] [Related]
13. Trends in antimicrobial susceptibility of Salmonella Typhi from North India (2001-2012).
Singhal L; Gupta PK; Kale P; Gautam V; Ray P
Indian J Med Microbiol; 2014; 32(2):149-52. PubMed ID: 24713900
[TBL] [Abstract][Full Text] [Related]
14. Reporting of Azithromycin Activity against Clinical Isolates of Extensively Drug-Resistant Salmonella enterica Serovar Typhi.
Jabeen K; Saleem S; Nizamuddin S; Arshad F; Jahan S; Hasnain F; Tariq W; Tahir MJ; Yousaf Z; Asghar MS
Am J Trop Med Hyg; 2023 May; 108(5):942-947. PubMed ID: 36940665
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of azithromycin, newer quinolones and cephalosporins in ciprofloxacin-resistant Salmonella causing enteric fever.
Capoor MR; Rawat D; Nair D; Hasan AS; Deb M; Aggarwal P; Pillai P
J Med Microbiol; 2007 Nov; 56(Pt 11):1490-1494. PubMed ID: 17965350
[TBL] [Abstract][Full Text] [Related]
16. Changing trends in antimicrobial resistance of Salmonella enterica serovar typhi and salmonella enterica serovar paratyphi A in Chennai.
Krishnan P; Stalin M; Balasubramanian S
Indian J Pathol Microbiol; 2009; 52(4):505-8. PubMed ID: 19805957
[TBL] [Abstract][Full Text] [Related]
17. Current pattern in antimicrobial susceptibility of Salmonella Typhi isolates in Pondicherry.
Madhulika U; Harish BN; Parija SC
Indian J Med Res; 2004 Aug; 120(2):111-4. PubMed ID: 15347861
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of azithromycin in Salmonella isolates from Pakistan.
Butt F; Sultan F
J Infect Dev Ctries; 2011 May; 5(5):391-5. PubMed ID: 21628817
[TBL] [Abstract][Full Text] [Related]
19. Current fluoroquinolone susceptibility criteria for Salmonella needs re-evaluation.
Acharya D; Malla S; Bhatta DR; Adhikari N; Dumre SP
Kathmandu Univ Med J (KUMJ); 2012; 10(37):24-9. PubMed ID: 22971857
[TBL] [Abstract][Full Text] [Related]
20. Is nalidixic acid screening still valid for the detection of reduced susceptibility of fluoroquinolone with Salmonella Typhi?
Irfan S; Jabeen K; Jilani UA; Ahmed B; Mehraj J; Ahsan T; Zafar A
J Infect Dev Ctries; 2012 Oct; 6(10):700-3. PubMed ID: 23103891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
